Has Warren Ellsworth, MD received payments from drug or device companies?

Yes. Drug and device makers reported $284,477 in general payments to Warren Ellsworth, MD across 389 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Warren Ellsworth, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Warren Ellsworth, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Warren Ellsworth, MD

Plastic Surgery · Houston, TXNPI 1336470343

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (58.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. AbbVie accounts for 73.3% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2022 at $81,092 and has fallen 62.7% since, to $30,212 in 2025. Among plastic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$284,477in general payments, 2019–2025

Across 389 payments — averaging $731.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$208K
Axogen$48K
Integra Lifesciences Corporation$9K
Sientra, Inc.$7K
Mentor Worldwide LLC$2K
Motiva USA, LLC$2K
plus $8K from 21 others

$74,466in research payments, 2019–2025

Across 12 payments — averaging $6205.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Axogen$74K

What the payments were for

Consulting fees$85,17630%
Speaking & faculty fees$165,37558%
Travel & lodging$12,5604%
Food & beverage$21,2807%
Gifts$870%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	189	$208,477
Axogen	59	$48,440
Integra Lifesciences Corporation	13	$9,500
Sientra, Inc.	18	$7,079
Mentor Worldwide LLC	31	$1,776
Motiva USA, LLC	10	$1,537
Merz North America, Inc.	6	$1,358
Biocircuit Technologies Inc	2	$1,250
Tepha Inc	14	$1,075
Aroa Biosurgery Incorporated	2	$858
TELA Bio, Inc.	6	$548
Davol Inc.	5	$474
Musculoskeletal Transplant Foundation Inc.	4	$396
Bard Peripheral Vascular, Inc.	4	$336
Zimmer Biomet	5	$246
Revance Therapeutics, Inc.	2	$213
RTI Surgical, Inc	2	$211
Kerecis Limited	3	$198
Alafair Biosciences, Inc.	1	$127
Johnson & Johnson	3	$74
BD	1	$73
Polynovo North America LLC	2	$67
Smith+Nephew	2	$45
Galderma Laboratories, L.p.	2	$40
Biotissue Holdings Inc.	1	$36
Stryker	1	$27
KCI USA, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NATRELLE SALINE-FILLED BREAST IMPLANTS$172,886
AxoGuard Nerve Connector$46,346
AxoGuard Nerve Protector$46,346
REVOLVE$30,735
AVANCE NERVE GRAFT$27,313
NATRELLE$15,815
ALLODERM$10,761
CODMAN CERTAS$6,496
SURGIMEND$6,496
SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$6,390
ARTIA RECONSTRUCTIVE TISSUE MATRIX$4,725
STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$3,176
DuraSorb Monofilament Mesh$2,579
Motiva Implant Matrix$1,295
Nerve Tape$1,250
MENTOR MemoryGel Resterilizable Gel Sizer$1,075
Kerecis SurgiClose$540
GalaFLEX$521
ARTOURA Breast Tissue Expander$511
INTEGRA$372

How this compares

$284,477 in reported general payments places this provider in the 95th percentile of 337 plastic surgery providers in Texas.

See all plastic surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$37,193

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	12	$39

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Houston

Younghoon ChoHouston$1.2M
David AdelmanHouston$405K
Camille CashHouston$212K
Robert YarishHouston$180K
Alexander MericliHouston$125K
Kristy HamiltonHouston$70K
Jenny NguyenHouston$45K
Patrick HsuHouston$34K
Anthony EchoHouston$27K
Matthew GreivesHouston$26K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →